Additional information
Light Yellow Powder
NA
ACI-121111
N6-(1-Carboxy-3-phenylpropyl)-N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline trisodium
(2S)-1-[(2S)-2,6-bis[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid trisodium
211.6-213.2°C
C31H38N3O7Na3
633.62
Ambient
2-8°C
2-Carboxylic acid trisodium, (2S)-1-[(2S)-2,6-bis[[(1S)-1-Carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-; (2S,2'S)-2,2'-(((S)-6-((S)-2-carboxypyrrolidin-1-yl)-6-oxohexane-1,5-diyl)bis(azanediyl))bis(4-phenylbutanoic Acid) trisodium;
Angiotensin-converting enzyme (ACE) inhibitors






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)